Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Compare which index fund is best after rolling over an IRA by examining expense ratios, tracking error, and portfolio breadth to support retirement goals.
27,882 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
NVIDIA helped turn early bets into life-changing gains. But can it keep delivering millionaire-maker returns? This pr...
A New Mexico jury found Meta's platforms harmful to children's mental health, ordering a $375 million penalty and sig...
Non-QM mortgage products are expanding to serve gig workers and freelancers, signaling a major shift in access to hom...
Ethereum has long relied on DeFi as its power source. As staking and Layer 2s grow, the big question is whether ether...
AI chip demand is reshaping tech markets, and Taiwan Semiconductor Manufacturing sits at the center. This article exp...
A mobility startup defies the VC playbook, raising $15 million from private investors. The story highlights disciplin...
Chicago-based MLS operator MRED formally pushes to compel arbitration with Zillow, placing a spotlight on contract la...
Paris tightens rules on short-term rentals, signaling a broader European crackdown on illegal Airbnb listings. Offici...
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
Sweetgreen faced a rough spell as the market punished sweetgreen that once looked unstoppable. Now, smart investors w...
Peloton posted a GAAP profit in its latest quarter and raised full-year guidance, sparking an 11% premarket jump as i...